Veeral Desai - Mar 16, 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Mar 16, 2022
Transactions value $
-$3,829,418
Form type
4
Date filed
3/18/2022, 04:16 PM
Previous filing
Sep 15, 2021
Next filing
Sep 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $197K +197K +75.31% $1.00* 459K Mar 16, 2022 Direct F1
transaction AGL Common Stock Sale -$4.03M -197K -42.96% $20.41 262K Mar 16, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Options Exercise $0 -197K -17.99% $0.00 900K Mar 16, 2022 Common Stock 197K $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 These options were granted on April 27, 2017 and fully vested on April 27, 2021.